Apotheek nieuws
- First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults
- Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism [Review article]
- Transparantieregister Zorg maakt jaarlijkse cijfers bekend
- Drug development outsourcing driving cost?effectiveness and efficiency in clinical research
- Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy
- Hoe je overmatig zweten onder controle houdt
- OKN-007 is an Effective Anticancer Therapeutic Agent Targeting Inflammatory and Immune Metabolism Pathways in Endometrial Cancer. [Drug Discovery and Translational Medicine]
- SCA44? and SCAR13?associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms
- A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants [Metabolism, Transport, and Pharmacogenetics]
- Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions [Therapeutic Approaches to Treat Disorders of the Genitourinary and Gastrointestinal Tracts]
- Dosing Time-Dependent Difference in the Suppressive Effect of Empagliflozin on the Development of Mechanical Pain Hypersensitivity in Diabetic Mice [Endocrine and Diabetes]
- Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors [Metabolism, Transport, and Pharmacogenetics]
- Toekomstvisie 2035: voor antwoorden op de uitdagingen van vandaag
- Grote Europese subsidie voor databank zeldzame hormoon- en botaandoeningen
- FDA to Review Sotagliflozin Application for Type 1 Diabetes Again